NCT06178549

Brief Summary

The goal of this study is to develop and evaluate an evidence-based public health intervention using HPV self-sampling approach in an opportunistic setting to increase cervical cancer screening among screening non-attendees, particularly those uninsured or underinsured, who use emergency services to access medical care. The proposed pilot study will examine the feasibility and efficacy of HPV self-sampling among women at a safety net hospital emergency room. Participant recruitment and self-sample will take place in the waiting rooms in the ER. All women sitting in the waiting room will serve as the source population for the study and will be approached and invited to participate in the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2023

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

December 12, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 21, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2024

Completed
Last Updated

January 15, 2025

Status Verified

June 1, 2024

Enrollment Period

5 months

First QC Date

December 12, 2023

Last Update Submit

January 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • HPV self-sampling completion

    Participation rate for self-sample HPV testing (percent of eligible women who complete self-sampling).

    1 day

Secondary Outcomes (2)

  • HPV self-sampling acceptability

    1 day

  • Attendance for cervical cancer screening among HR-HPV positive women

    6 months

Study Arms (1)

Intervention arm (single arm)

EXPERIMENTAL

Intervention arm to complete HPV self-sampling

Behavioral: HPV Self-Sampling

Interventions

HPV self-sampling. Participants will be provided with education regarding cervical cancer prevention and Aptima kit and instructions for self-sampling. Patient navigators will assist participants with positive HPV test results to connect with healthcare providers for follow-up screening and care.

Intervention arm (single arm)

Eligibility Criteria

Age25 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible participants are women ages 25 years to 65 years, with a cervix, presenting in the waiting areas at the Ben Taub General Hospital Emergency Department

You may not qualify if:

  • Women under 25 years or older than 65 years of age,
  • self-reported current pregnancy,
  • self-reported history of cervical cancer,
  • past hysterectomy,
  • had Pap Smear within past 3 years or HPV/Pap co-test within past 5 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 12, 2023

First Posted

December 21, 2023

Study Start

November 15, 2023

Primary Completion

April 11, 2024

Study Completion

October 11, 2024

Last Updated

January 15, 2025

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations